• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检查的淋巴结计数与 pN0 胸段食管癌老年患者的预后无关。

Examined lymph node count is not associated with prognosis in elderly patients with pN0 thoracic esophageal cancer.

机构信息

Department of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou.

Department of Thoracic Surgery, Anyang Tumor Hospital, Anyang, Henan Province, China.

出版信息

Medicine (Baltimore). 2021 Jan 15;100(2):e24100. doi: 10.1097/MD.0000000000024100.

DOI:10.1097/MD.0000000000024100
PMID:33466178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7808502/
Abstract

The purpose of this study was to determine whether the number of lymph nodes dissected predicts prognosis in surgically treated elderly patients with pN0 thoracic esophageal cancer. We searched the Surveillance, Epidemiology, and End Results database and identified the records of younger (<75 years) and older (≥75 years) patients with pN0 thoracic esophageal cancer between 1998 and 2015. The patient characteristics, tumor data, and postoperative variables were analyzed in this study. The Kaplan-Meier method and a Cox proportional hazard model were used to compare overall and cause-specific survival. Data from 1,792 esophageal cancer patients (older: n = 295; younger: n = 1497) were included. The survival analysis showed that the overall and cause-specific survival in the patients with ≥15 examined lymph nodes (eLNs) was significantly superior to that in the patients with 1 to 14 eLNs (P < .001); however, the difference disappeared in the older patients. After stratification by the tumor location, histology, pT classification, and differentiation between the younger and older cohorts to analyze the association between eLNs and survival, we found that the differences remained significant in most subgroups in the younger cohort. There were no differences in any subgroups of older patients. This study replicated the previously identified finding that long-term survival in patients with extensive lymphadenectomy was significantly superior to that in patients with less extensive lymphadenectomy. However, less extensive lymphadenectomy may be an acceptable treatment modality for elderly patients with pN0 thoracic esophageal cancer.

摘要

本研究旨在确定淋巴结清扫数目是否可预测手术治疗的 pN0 胸段食管鳞癌老年患者的预后。我们检索了 Surveillance, Epidemiology, and End Results(SEER)数据库,并纳入了 1998 年至 2015 年间年龄小于 75 岁(年轻组)和年龄大于等于 75 岁(老年组)的 pN0 胸段食管鳞癌患者的记录。本研究分析了患者特征、肿瘤数据和术后变量。采用 Kaplan-Meier 法和 Cox 比例风险模型比较总生存期和疾病特异性生存期。共纳入 1792 例食管癌患者(老年组:n=295;年轻组:n=1497)。生存分析显示,淋巴结清扫数≥15 枚(eLNs)患者的总生存期和疾病特异性生存期明显优于清扫数 1~14 枚(eLNs)的患者(P<0.001);然而,这一差异在老年患者中消失。在按肿瘤位置、组织学、pT 分期和年轻与老年队列分层分析 eLNs 与生存的关系后,我们发现 eLNs 与生存的关联在年轻队列的大多数亚组中仍然显著,而在老年患者的任何亚组中均无差异。本研究复制了先前发现的广泛淋巴结清扫术患者的长期生存明显优于较少淋巴结清扫术患者的结果。然而,较少的淋巴结清扫术可能是治疗 pN0 胸段食管鳞癌老年患者的一种可接受的治疗方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f978/7808502/bd02d8b3d099/medi-100-e24100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f978/7808502/13da455abbef/medi-100-e24100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f978/7808502/bd02d8b3d099/medi-100-e24100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f978/7808502/13da455abbef/medi-100-e24100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f978/7808502/bd02d8b3d099/medi-100-e24100-g002.jpg

相似文献

1
Examined lymph node count is not associated with prognosis in elderly patients with pN0 thoracic esophageal cancer.检查的淋巴结计数与 pN0 胸段食管癌老年患者的预后无关。
Medicine (Baltimore). 2021 Jan 15;100(2):e24100. doi: 10.1097/MD.0000000000024100.
2
Limited Lymph Node Resection Does Not Decrease Postoperative Mortality After Esophagectomy in Octogenarians With Thoracic Esophageal Cancer.局限性淋巴结清扫术并未降低 80 岁以上胸段食管癌患者术后死亡率。
J Surg Res. 2021 Mar;259:538-545. doi: 10.1016/j.jss.2020.10.006. Epub 2020 Nov 6.
3
Should the clinical significance of supraclavicular and celiac lymph node metastasis in thoracic esophageal cancer be reevaluated?胸段食管癌锁骨上和腹腔淋巴结转移的临床意义是否需要重新评估?
Thorac Cancer. 2019 Aug;10(8):1725-1735. doi: 10.1111/1759-7714.13144. Epub 2019 Jul 10.
4
[Efficacy comparison between two-field and three-field lymphadenectomy for thoracic esophageal squamous cell carcinoma].[胸段食管鳞状细胞癌两野与三野淋巴结清扫术的疗效比较]
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Sep 25;19(9):990-994.
5
Adjuvant radiation therapy and lymphadenectomy in esophageal cancer: a SEER database analysis.食管癌辅助放疗和淋巴结清扫术:SEER 数据库分析。
J Gastrointest Surg. 2013 Aug;17(8):1339-45. doi: 10.1007/s11605-013-2192-7. Epub 2013 Jun 8.
6
[Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].[胸段食管癌手术切除术后患者的生存分析]
Zhonghua Zhong Liu Za Zhi. 2009 Jul;31(7):541-5.
7
Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients.T1 期食管癌患者淋巴结清扫范围对生存的预后价值。
BMC Cancer. 2021 Apr 14;21(1):403. doi: 10.1186/s12885-021-08080-4.
8
Comparison of Ivor-Lewis versus Sweet procedure for middle and lower thoracic esophageal squamous cell carcinoma: A STROBE compliant study.Ivor-Lewis术式与Sweet术式治疗胸段中下段食管鳞状细胞癌的比较:一项遵循STROBE规范的研究
Medicine (Baltimore). 2019 Feb;98(6):e14416. doi: 10.1097/MD.0000000000014416.
9
Development and validation of nodal staging score in pN0 patients with esophageal squamous cell carcinoma: A population study from the SEER database and a single-institution cohort.基于 SEER 数据库人群研究和单中心队列研究的食管鳞癌 pN0 患者淋巴结分期评分的建立和验证
Thorac Cancer. 2022 Dec;13(23):3257-3267. doi: 10.1111/1759-7714.14670. Epub 2022 Oct 11.
10
Prognostic significance of lymph node count in surgically treated patients with T stage nonmetastatic adrenocortical carcinoma.淋巴结计数对 T 期无转移肾上腺皮质癌手术治疗患者的预后意义。
Urol Oncol. 2024 Aug;42(8):248.e1-248.e9. doi: 10.1016/j.urolonc.2024.04.003. Epub 2024 Apr 23.

引用本文的文献

1
Impact of the number of lymph node dissections and a novel risk stratification on the prognosis in elderly locally advanced esophageal adenocarcinoma.淋巴结清扫数量及一种新的风险分层对老年局部晚期食管腺癌预后的影响
J Cancer. 2024 Jun 3;15(13):4197-4204. doi: 10.7150/jca.96574. eCollection 2024.
2
Efficacy and safety of camrelizumab in combination with neoadjuvant chemotherapy for ESCC and its impact on esophagectomy.卡瑞利珠单抗联合新辅助化疗治疗 ESCC 的疗效和安全性及其对食管癌切除术的影响。
Front Immunol. 2022 Jul 14;13:953229. doi: 10.3389/fimmu.2022.953229. eCollection 2022.